Research Grade Clivatuzumab (DHD14205) Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Research Grade Clivatuzumab (DHD14205) Usage And Synthesis

Uses

Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1].

References

[1] Gold DV, et al. Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin. Mol Cancer. 2013 Nov 20;12(1):143. DOI:10.1186/1476-4598-12-143

Research Grade Clivatuzumab (DHD14205)(1622075-09-5)Related Product Information

• Berlimatoxumab
• Astegolimab
• Timigutuzumab
• Perakizumab
• Opucolimab
• Monoclonal antibody 6B1 igg4
• Cabiralizumab
• Plonmarlimab
• Lacnotuzumab
• Ivicentamab